FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Sodium Chloride 23.4% Injection
Status: Currently in Shortage
»Date first posted: 01/01/2020
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Fresenius Kabi USA, LLC (Revised 04/18/2024)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Sodium Chloride 23.4%, Injection, 4 meq/1 mL (NDC 63323-093-30)	Unavailable	Backordered. Next release May 2024; Check wholesaler inventory; old NDC 63323-187-30	Demand increase for the drug
Sodium Chloride 23.4%, Injection, 4 meq/1 mL (NDC 63323-099-63)	Available	Check wholesaler inventory; old NDC 63323-088-63

Hospira, Inc., a Pfizer Company (Revised 03/28/2024)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Sodium Chloride, Injection, 400 mEq/100 mL (4 mEq/mL) (NDC 0409-1141-02)	Limited Availability	Limited Supply Available. Next Delivery: May 2024; Estimated Recovery: September 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Demand increase for the drug